Adverse immunological responses against non-viral nanoparticle (NP) delivery systems in the lung

There is a large, unmet medical need to treat chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis and other respiratory diseases. New modalities are being developed, including gene therapy which treats the disease at the DNA/RNA level. Despite recent innovations in non-viral...

Descripción completa

Detalles Bibliográficos
Autores principales: de Braganca, Leonor, Ferguson, G. John, Luis Santos, Jose, Derrick, Jeremy P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788408/
https://www.ncbi.nlm.nih.gov/pubmed/33956565
http://dx.doi.org/10.1080/1547691X.2021.1902432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788408/
https://www.ncbi.nlm.nih.gov/pubmed/33956565
http://dx.doi.org/10.1080/1547691X.2021.1902432

Ejemplares similares